he federal government says Canada will start shipping its experimental Ebola vaccine to the World Health Organization on Monday.
The government says in a release the Public Health Agency of Canada is supplying the vaccine to the UN body in Geneva in its role as the international co-ordinating body for the Ebola outbreak in West Africa. It says Canada will ship 800 vials of its experimental vaccine in three separate shipments, as a precautionary measure.
The WHO will consult with its partners, including the health authorities from the affected countries, to determine how best to distribute and use the vaccine. For instance, it must take into account concerns about using an experimental vaccine in people.
The government announced last month that clinical trials had started in the United States on a Canadian-made Ebola vaccine, with results expected in December.
The WHO says the Ebola outbreak has killed more than 4,500 people in West Africa.
“This vaccine, the product of many years of scientific research and innovation, could be an important tool in curbing the outbreak,” said Dr. Gregory Taylor of the public health agency.
I need help reading this article.. What are the main points of the article and what happened or expected to happen?
The first sentence tells what the article is about.
The rest is background material until you get to the last sentence which explains what the outcome might be.
I need to ask one question... Why Canada involved?
1. Canada wants to help the people of Africa.
2. A Canadian company made this vaccine.
The main points of the article are as follows:
1. Canada will start shipping its experimental Ebola vaccine to the World Health Organization (WHO) on Monday.
2. The Public Health Agency of Canada is supplying the vaccine to the WHO as part of its role as the international coordinating body for the Ebola outbreak in West Africa.
3. Canada will send 800 vials of its experimental vaccine in three separate shipments as a precautionary measure.
4. The WHO will consult with its partners, including health authorities from affected countries, to determine how best to distribute and use the vaccine.
5. Clinical trials for the Canadian-made Ebola vaccine began in the United States last month, with expected results in December.
6. The WHO reports that the Ebola outbreak has already claimed the lives of more than 4,500 people in West Africa.
7. Dr. Gregory Taylor of the Public Health Agency of Canada highlights the potential significance of the vaccine in curbing the outbreak.
In summary, Canada is sending its experimental Ebola vaccine to the WHO to be distributed and used in fighting the Ebola outbreak in West Africa. The vaccine is seen as an important tool in combating the outbreak, and its effectiveness will be assessed through clinical trials.